RxPepsDirect vs Henry Meds

"Henry Meds alternative" is one of the most common searches in peptide telehealth, and most of the people typing it are not unhappy with Henry. They have simply outgrown a menu built around GLP-1 weight loss. This is an honest, side-by-side comparison of the two services across pricing, formulary, formulations, state coverage, the clinician model, and the pharmacy partner. We sell peptides, so read the "when Henry makes sense" section as proof that this is a real comparison and not a one-sided pitch.

1. What Henry Meds offers (GLP-1, sermorelin, BPC-157)

Henry Meds built its brand on accessible GLP-1 weight loss. Its center of gravity is compounded and branded GLP-1 medication (semaglutide and tirzepatide class), delivered through a clean, consumer-friendly subscription. Around that core, Henry attaches a small set of wellness peptides, most visibly sermorelin for growth hormone support and BPC-157 for recovery.

The strength of this model is focus. A patient who wants a GLP-1 and maybe one recovery peptide gets a tidy, low-decision experience: pick the plan, complete intake, and the medication arrives on a recurring schedule. Henry is not trying to be a deep peptide pharmacy, and for the GLP-1-first buyer that restraint is a feature, not a limitation.

The GLP-1 evidence base behind that core is genuinely strong. According to PubMed, the SURMOUNT-1 phase 3 randomized trial of once-weekly tirzepatide produced mean weight reductions of roughly 15 to 21 percent over 72 weeks depending on dose (Jastreboff et al., 2022). That is the science Henry is packaging, and it is real.

2. What RxPepsDirect offers (full peptide formulary)

RxPepsDirect approaches the same patient from the opposite direction. Instead of leading with a single weight loss drug and bolting on a few extras, it publishes a 55-plus peptide formulary with per-vial pricing on every item. GLP-1s are part of the catalog, but so are growth hormone secretagogues, recovery stacks, sexual health peptides, longevity compounds, and a small cognitive line.

The categories Henry does not meaningfully cover are where RxPepsDirect is built to win:

One important honesty note up front: RxPepsDirect writes the prescription only. The medication is filled, shipped, and billed by Optimal Balance Pharmacy, a 503A licensed compounding pharmacy. RxPepsDirect does not dispense, ship, or sell the medication itself. That two-party structure is the backbone of the pricing model described below.

3. Pricing model: Henry’s subscription vs RxPeps’s flat visit + pass-through

This is the single biggest structural difference between the two services, so it is worth being precise.

Henry Meds uses a subscription: medication, provider access, and shipping are bundled into one recurring monthly charge. The advertised number is easy to understand, but it blends the cost of the drug with the cost of the service, so the true per-vial price is hard to isolate.

RxPepsDirect splits the bill into two parties:

1. A $39 medical visit fee, billed by RxPepsDirect, that covers the provider intake review and the prescription. One visit can cover up to three peptides.
2. The medication itself, billed separately by Optimal Balance Pharmacy at wholesale, priced per vial. For example, sermorelin is $80 per 15mg vial, BPC-157 is $80 per 15mg vial, the Wolverine Stack (BPC-157/TB-500) is $100 per 15mg + 15mg vial, and tesamorelin is $100 per 15mg vial.

The practical consequence: there is no recurring RxPepsDirect membership. You pay the visit fee when you need a prescription written, and you pay the pharmacy for what you actually fill. For a multi-peptide protocol, this usually undercuts a per-product subscription. For a single GLP-1 that you intend to run indefinitely, a bundled subscription can feel simpler even if the math is less transparent.

4. Peptide breadth comparison

Breadth is the clearest dividing line. Henry Meds carries a small, curated set of peptides anchored to GLP-1 weight loss. RxPepsDirect lists 55-plus peptides across the full therapeutic range.

If your needs stop at a GLP-1 and one recovery peptide, the breadth gap is irrelevant to you. If you run a multi-system protocol, it is the whole story.

5. Carrier formulations

A detail most comparisons skip: how the peptide is formulated. The GLP-1s RxPepsDirect prescribes are compounded with carrier additives rather than as a bare molecule. The catalog pairs semaglutide and tirzepatide with B-12 or with B6 plus glycine carriers depending on the variant. This is a formulation choice the 503A pharmacy makes, not a purity claim. We do not publish HPLC purity data, and our certificates of analysis cover sterility and endotoxin, so we describe carriers factually rather than implying they make the product "purer."

Injectable peptides prescribed through RxPepsDirect arrive pre-reconstituted, FedEx overnight, in a reusable cooled travel case, fulfilled by Optimal Balance Pharmacy. You do not mix anything yourself. Henry Meds also ships ready-to-use formats for its GLP-1 line. The meaningful difference is variety: RxPepsDirect exposes multiple carrier and dose formats per molecule, while Henry keeps its formats narrow and standardized in service of its simpler menu.

6. State coverage

Henry Meds advertises broad nationwide availability for its weight loss core. RxPepsDirect’s peptide service is available in 28 U.S. states as of June 2026, a footprint determined by where its prescribers hold licensure. This is an honest limitation: a service built on a small prescriber roster covers fewer states than a large weight loss brand with a wide clinician network.

The states that matter to you are the ones where both operate, since that overlap is where a real head-to-head choice exists. Because each company updates its map on its own schedule, the only reliable move is to confirm your specific state on each site before committing. Do not assume that nationwide GLP-1 availability implies nationwide peptide availability; they are governed by different licensure and supply constraints.

7. Clinician model

Both services use licensed telehealth providers and asynchronous intake rather than in-person visits. The difference is positioning. Henry Meds runs a high-volume, weight-loss-first clinician model optimized for a narrow set of GLP-1 protocols, which keeps the patient experience simple and repeatable.

RxPepsDirect’s providers review intakes across a much wider formulary, which means more provider judgment per case: a patient asking for a GH secretagogue stack plus a recovery peptide needs a different review than a single GLP-1 request. RxPepsDirect medical oversight is led by Medical Director Dr. Jonathan Snipes (NPI 1821250077), with Kim Callender, FNP-BC, as lead prescriber. Neither model is "better" in the abstract; a narrow menu rewards a streamlined clinician flow, and a broad menu rewards more individualized review.

8. Pharmacy partner comparison

RxPepsDirect fills through a single named 503A partner: Optimal Balance Pharmacy. That pharmacy fills, ships, and collects payment for the medication, while RxPepsDirect handles only the prescription and the $39 visit. Naming the pharmacy publicly is deliberate, it lets a patient verify the 503A licensure and the certificate-of-analysis scope (sterility and endotoxin) for what they are putting in their body.

Henry Meds works with its own compounding pharmacy network for fulfillment, bundled inside the subscription. For most buyers the bundling is convenient. For a buyer who wants to know exactly which pharmacy compounds their peptide and what the testing scope is, RxPepsDirect’s single-named-partner model is more transparent by design. We do not claim purity beyond what the COAs actually cover.

9. Intake process

The two intakes are structurally similar and differ mainly in scope:

1. Online health history. Both services collect medical history, current medications, and goals through a structured online form. No in-person clinic visit is required by either.
2. Provider review. Henry’s review is tuned for GLP-1 eligibility. RxPepsDirect’s review spans the broader formulary and screens for peptide-specific contraindications.
3. Prescription and fill. Henry routes the script into its bundled subscription fulfillment. RxPepsDirect sends the prescription to Optimal Balance Pharmacy, which fills and ships pre-reconstituted product FedEx overnight in a reusable cooled travel case and collects the medication payment separately.
4. Billing. Henry charges one recurring subscription. RxPepsDirect charges a one-time $39 visit fee, with the pharmacy billing the medication per vial.

Note that there is no script "transfer" between the services. Moving from Henry to RxPepsDirect means completing a fresh RxPepsDirect intake and a new independent provider review, not porting an existing prescription.

10. When Henry makes sense, when RxPeps makes sense

The honest version of this comparison is that the two services are optimized for different buyers.

When Henry Meds makes sense

• You primarily want a GLP-1 weight loss plan and value a single bundled monthly charge over itemized pricing.
• Your protocol stops at a GLP-1 plus, at most, sermorelin or BPC-157.
• You want the simplest possible decision and a polished consumer experience, and you live in a state RxPepsDirect does not yet cover.

When RxPepsDirect makes sense

• You run a multi-peptide protocol spanning GH secretagogues, recovery, sexual health, or cognitive categories that Henry does not carry.
• You want transparent per-vial pricing and no recurring membership, paying a flat $39 visit fee plus pharmacy cost.
• You want to know the named 503A pharmacy (Optimal Balance) and the certificate-of-analysis scope behind your medication, and you live in one of the 28 covered states.

11. Side-by-side table

A note on evidence quality, because honesty cuts both ways. The GLP-1 weight loss data both companies rely on is strong and trial-backed. The growth hormone secretagogue data (sermorelin, tesamorelin, CJC-1295/Ipamorelin) is real but more modest, with tesamorelin the best-evidenced of the group. The recovery peptides (BPC-157, TB-500) rest mostly on preclinical and anecdotal support with thin or absent human randomized data, and the cognitive peptides are earlier still. Neither service can honestly promise outcomes for the thinner-evidence categories, and any that does is overselling.